Status:
RECRUITING
Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
University of Helsinki
Conditions:
High Grade Ovarian Serous Adenocarcinoma
High Grade Serous Carcinoma
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Chemotherapy resistance is the greatest contributor to mortality in advanced cancers and severe challenges remain in finding effective treatment modalities to cancer patients with metastasized and rel...
Detailed Description
Specific aims include: * Develop tools and methods for personalized medicine approaches to cancer patients. * Develop open-source visualization and interpretation software that facilitate clinical de...
Eligibility Criteria
Inclusion
- Patients with a suspected ovarian cancer diagnosis treated at the Turku University Hospital
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Age \<18 years, too poor condition for active treatment (surgery, chemotherapy)
- FDG PET/CT scan is not performed for patients with diabetes mellitus and poor glucose balance.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04846933
Start Date
February 1 2012
End Date
December 1 2029
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital
Turku, Finland, 20520